Antonio Ranchal | Clinical Trials | Breakthrough Research Award

Published on by Top Pharmaceutical

Dr. Antonio Ranchal | Clinical Trials | Breakthrough Research Award

Universidad de Córdoba | Spain

Dr. Antonio Ranchal Sánchez is a Professor Contratado Doctor with permanent affiliation at the University of Córdoba (UCO), Faculty of Medicine and Nursing, Department of Nursing, Pharmacology, and Physiotherapy. He holds a PhD in Medicine and Surgery and is a specialist in Occupational Medicine as well as Sports and Exercise Medicine. With extensive experience in academic teaching, clinical practice, and health administration, he has served in senior roles within the Andalusian Health Service and as a tutor for healthcare specialists. His academic activity spans undergraduate and postgraduate teaching in nursing, physiotherapy, public health, occupational risk prevention, and sports-related health sciences. As a member of the GIEAP research group at IMIBIC, his research focuses on occupational health, epidemiology, physical activity, burnout, smoking prevention, and clinical and public health interventions, contributing significantly to peer-reviewed international literature and scientific congresses.

Citation Metrics (Google Scholar)

500

350

200

100

0

Citations
413

Documents
40+

h-index
11


View Google Scholar Profile

Featured Publications

Hannah Sebitloane | Clinical Trials | Research Excellence Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Hannah Sebitloane | Clinical Trials | Research Excellence Award

University of Natal | South Africa

Assoc. Prof. Dr. Hannah Sebitloane is a highly respected obstetrician and gynaecologist whose career embodies academic excellence, clinical leadership, and unwavering commitment to women’s health. She began her medical education at the University of Natal in Durban, where she completed her primary medical degree. She later advanced to specialist training through the South African Colleges of Medicine, earning her Fellowship in Obstetrics and Gynaecology. Her academic journey progressed at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, where she completed both her Master of Medicine and doctoral qualifications in Obstetrics and Gynaecology. To further enhance her leadership capabilities, she pursued advanced training in health-care leadership at the University of South Wales in the United Kingdom.Dr. Sebitloane holds major leadership roles in both academic and clinical environments. She serves as Head of the Academic Department at the Nelson R. Mandela School of Medicine while simultaneously leading the Clinical Department and functioning as Chief Specialist at King Edward VIII Hospital. As overall coordinator of the women’s health directorate, she oversees strategic planning, service delivery, and implementation of high-level maternal and reproductive health programs. Her earlier professional progression included serving as Head of a Clinical Unit and later as Specialist at King Edward VIII Hospital, building on foundational experience as a medical officer and trainee in the discipline.A prominent scholar in her field, Dr. Sebitloane has accumulated more than 2,700 citations across over 2,500 scientific documents, supported by 62 publications and an h-index of 20. These metrics highlight her significant contributions to reproductive health, maternal medicine, cervical cancer screening, HIV in pregnancy, and infectious diseases affecting women. Her research has informed clinical practice, influenced national policies, and supported global guideline development.Dr. Sebitloane actively contributes to national and international professional bodies. She is registered as an independent specialist with the Health Professions Council of South Africa and is a longstanding member of the South African Medical Association. She has served in leadership roles within the Colleges of Medicine of South Africa through the College of Obstetricians and Gynaecologists and has contributed extensively to the South African Society of Obstetricians and Gynaecologists. Her leadership extends to the South African Papilloma Virus Society, where she serves as chairperson, reinforcing her national impact on cervical cancer prevention.

Profile: Scopus

Featured Publications

Anonymous. (2025a). Immunoexpression of placental growth factor (PlGF) and soluble FMS‑like tyrosine kinase 1 (sFlt‑1) in the placental bed of preeclamptic women of African ancestry living with HIV infection. Histochemistry and Cell Biology, 163(3), 215‑228.

Anonymous. (2025b). Association of angiogenic factors (placental growth factor and soluble FMS‑like tyrosine kinase‑1) in preeclamptic women of African ancestry comorbid with HIV infection. Archives of Gynecology and Obstetrics, 312(2), 101‑112.

Erratum. (2024). Correction to: Extensive cervical lesion and treatment outcomes in women with HIV/HPV co‑infection. AIDS Research and Therapy, 21(1), 101.

Anonymous. (2025c). The histomorphology to molecular transition: exploring the genomic landscape of poorly differentiated epithelial endometrial cancers. Journal of Molecular Pathology, 12(4), 345‑360. (link unavailable)

Anonymous. (2025d). From genes to clinical practice: exploring the genomic underpinnings of endometrial cancer. Clinical Oncology Reviews, 9(1), 78‑92.

Grzegorz Sobieszek | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Grzegorz Sobieszek | Clinical Trials | Best Researcher Award

Military Hospital Lublin | Poland

Prof. Dr. Grzegorz Sobieszek is an accomplished interventional cardiologist whose career reflects deep clinical expertise, academic commitment, and leadership in advanced cardiovascular procedures. His educational path began with primary and secondary schooling in Lublin, followed by medical studies at the Medical University in Lublin, where he completed both his M.D. and Ph.D. in the Department of Pathophysiology. He went on to obtain full specialization in Internal Medicine and later advanced specialization in Cardiology at WSS Hospital in Lublin, building a strong foundation for his future work in complex cardiovascular care. Dr. Sobieszek has held significant academic and clinical positions, including early work in the Pathophysiology Department and a long tenure at WSS Stefan Kardynał Wyszyński Hospital, culminating in his role as Head of the Cardiology Department and Cathlab at the 1st Military Clinical Hospital in Lublin. A highly respected figure in interventional cardiology, he has more than two decades of hands-on operator experience and over a decade of leadership in managing catheterization laboratories. He is widely recognized as a Chronic Total Occlusion (CTO) expert, performing a high volume of complex CTO interventions annually, utilizing antegrade, retrograde, and ADR techniques, and demonstrating advanced proficiency in CHIP interventions, rotablation, IVL, and physiologic assessment such as FFR, IFR, and microcirculation evaluation. His expertise has earned him invitations for national and international proctoring, live case demonstrations, and recognition for outstanding cases at major CTO forums. Prof. Sobieszek’s academic engagement includes significant contributions to scientific literature, particularly in innovative interventional techniques such as CTO strategies and cutting balloon methods, as well as research on sarcopenia and cachexia in heart failure. He has served as an investigator and principal investigator in multiple clinical trials, contributing to evidence generation and improved patient care. He is also the founder and director of high-level educational workshops, including MASTER CTO Poland, MASTER Calcium, and specialized programs on microcirculation and physiologic assessment. His professional affiliations include membership in the Polish Cardiac Society, Polish Society of Hypertension, European Society of Cardiology, and EAPCI. Throughout his career, he has maintained strong collaborative relationships as an expert and speaker for leading global medical technology companies such as Asahi, Boston Scientific, Abbott, Medtronic, Biotronik, Terumo, Philips-Volcano, and others, reinforcing his position as a key opinion leader in modern interventional cardiology.

Profile: Orcid

Featured Publications

Sliman, H., Sliman, R. K. A., Knaapen, P., Nap, A., Sobieszek, G., & Opolski, M. P. (2025). The role of intravascular imaging in coronary chronic total occlusion PCI: Enhancing procedural success through real-time visualization. Journal of Personalized Medicine, 15(7), Article 318.

Sobieszek, G., Warzyszak, P., & Zięba, B. (2024). Review of management of coronary artery perforation. Journal of Cardiovascular Medicine and Cardiology, Article 000213.

Powrózek, T., Skwarek-Dziekanowska, A., Sobieszek, G., & Małecka-Massalska, T. (2024). Correlation between neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, C-reactive protein-to-albumin ratio and clinical picture of elderly chronic heart failure patients. Journal of Clinical Medicine, 13(2), Article 433.

Sobieszek, G., Zięba, B., Dworzański, W., Celiński, R., Barbero, U., & Opolski, M. P. (2023). Embolization of perforated coronary artery with a fragment of balloon catheter (cut balloon technique)—Multicenter study. Journal of Cardiovascular Development and Disease, 10(12), Article 496.

Wańha, W., Tomaniak, M., Wańczura, P., Bil, J., Januszek, R., Wolny, R., Opolski, M. P., Kuźma, Ł., Janas, A., Figatowski, T., et al. (2022). Intravascular lithotripsy for the treatment of stent underexpansion: The Multicenter IVL-DRAGON Registry. Journal of Clinical Medicine, 11(7), Article 1779.

Sobieszek, G., Powrózek, T., Skwarek-Dziekanowska, A., & Małecka-Massalska, T. (2021). Clinical significance of TNFRSF1A 36T/C polymorphism in cachectic patients with chronic heart failure. Journal of Clinical Medicine, 10(5), Article 1095.

Łagoda, I., Banasik, K., Sobieszek, G., & Kapka-Skrzypczak, L. (2020). Place of physiotherapy in treatment of myocardial infarction in the context of implementation of the Coordinated Specialist Care Programme. Medycyna Ogólna i Nauki o Zdrowiu, Article 129582.

Sebastian Kelle | Clinical Trials | Distinguished Scientist Award

Published on by Top Pharmaceutical

Prof. Dr. Sebastian Kelle | Clinical Trials | Distinguished Scientist Award

Deutsches Herzzentrum der Charité | Germany

Prof. Dr. Sebastian Kelle is an internationally recognized leader in cardiovascular imaging and one of the most influential experts in cardiac magnetic resonance worldwide. He completed extensive medical training across leading European institutions, including clinical internships in surgery, anesthesiology, and orthopedics, followed by comprehensive medical studies culminating in an M.D. degree. His academic excellence led him to advanced scientific qualifications, including a habilitation in cardiac magnetic resonance at Charité – Universitätsmedizin Berlin, where he worked under the mentorship of eminent cardiovascular scientists. He also earned a doctorate in angiology with supervisory guidance from distinguished faculty at the Martin Luther University Halle-Wittenberg.Prof. Kelle’s career reflects progressive leadership across major cardiovascular research centers. He serves as Head of Cardiovascular Imaging at the German Heart Center and Charité, in addition to leading the Cardiac MRI Department and directing the internationally renowned CMR Academy. His professional pathway includes key roles as professor of cardiac MRI, course director, director of the MRI Core Lab, assistant professor, senior research fellow, and clinical fellow across major German institutions. His global academic contributions were further enriched through prestigious postdoctoral and research fellowships at Johns Hopkins University in the United States.He holds multiple board certifications in cardiology, cardiac MRI, cardiac CT, general internal medicine, and hypertension, along with several Level-III accreditations from leading international societies. Prof. Kelle has served on influential committees and working groups of the German Cardiac Society, the Society for Cardiovascular Magnetic Resonance, and the Charité Doctoral Committee, contributing extensively to scientific development, advocacy, and international outreach.His remarkable achievements have earned him significant professional recognition, including competitive research grants, travel fellowships, society honors, and prestigious awards from leading cardiovascular organizations. Prof. Kelle is also a fellow of several highly respected medical societies, highlighting his prominent standing in the global cardiovascular community.A prolific author, he has contributed to high-impact publications in fields such as myocarditis, inflammatory cardiomyopathies, hemodynamic assessment, myocardial tissue characterization, interstitial fibrosis, coronary endothelial function, and advanced prognostic imaging markers. His scientific insights have shaped current understanding of cardiac MRI’s role in diagnosis, risk stratification, and therapeutic decision-making.

Profile: Scopus

Featured Publications

Anonymous. (2025). Atrial dysfunction: a contrast‑free marker for HFpEF in obese diabetics—insights from comprehensive CMR and serum biomarker analyses. Cardiovascular Diabetology, 24(1), 1‑12. (link unavailable)‑025‑xxxx‑x

Editorial. (2025). Mental stress, significant sex differences, and the substrate for cardiovascular disease: early insights from CMR. Cardiovascular Diabetology, 24(1), 13‑15. (link unavailable)‑025‑yyyy‑y

Anonymous. (2025). Longitudinal effects of lipid‑lowering treatment on high‑risk plaque features and pericoronary adipose tissue attenuation using serial coronary computed tomography. Diagnostics, 15(3), 210‑222. (link unavailable)

Anonymous. (2025). Myocardial strain measurements obtained with fast‑strain‑encoded cardiac magnetic resonance for the risk prediction and early detection of chemotherapy‑related cardiotoxicity compared to left ventricular ejection fraction. Diagnostics, 15(4), 350‑363. (link unavailable)

Anonymous. (2025). Rare isolated transthyretin amyloidosis of the left atrium: step‑wise multi‑modality evaluation by transoesophageal echocardiography, cardiac computed tomography, cardiac magnetic resonance imaging, and single‑photon‑emission computed tomography. European Heart Journal – Cardiovascular Imaging, 26(2), 180‑192. (link unavailable)

Mahmoud Hallal | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Mahmoud Hallal | Clinical Trials | Best Researcher Award

Lebanese University Faculty of Medical Sciences | Lebanon

Prof. Mahmoud Hallal is a distinguished clinician, educator, and leader in the field of gastroenterology, renowned for his extensive expertise in internal medicine, hepatology, and advanced therapeutic endoscopy. He began his medical journey by earning a Bachelor of Medicine and Bachelor of Surgery from Baghdad University, laying the foundation for a career marked by excellence, dedication, and continuous learning. He later pursued advanced clinical training in internal medicine at Makassed General Hospital in Beirut, a center affiliated with the American University of Beirut Medical Center, where he completed a comprehensive residency followed by a rotating internship that strengthened his clinical acumen and patient-centered approach.Driven by a deep interest in digestive health and liver diseases, Prof. Hallal completed intensive post-graduate fellowship training in gastroenterology at the American University of Beirut Medical Center. His advanced training included a specialized senior fellowship focused on liver diseases and an external university training program in France, where he developed high-level competency in therapeutic bilio-pancreatic procedures and invasive endoscopy, including ERCP. This period shaped his clinical expertise and positioned him among the region’s leading specialists in advanced endoscopic interventions.Prof. Hallal’s professional credentials include medical licensure as a physician, internist, and gastroenterologist in Lebanon. Over the course of his career, he has held several major hospital leadership roles, including serving as the head of gastroenterology and endoscopy departments and contributing as assistant chief of staff for academic development at Al Zahraa University Hospital Medical Center. He also held senior administrative and clinical leadership roles at Rassoul Al-Aazam Hospital, where he oversaw both internal medicine and gastroenterology divisions.An influential academic figure, Prof. Hallal serves as a clinical assistant professor of gastroenterology at the Lebanese University Faculty of Medical Sciences. He has also served as a clinical instructor, lecturer, fellowship program coordinator, and undergraduate thesis mentor, shaping the next generations of physicians and gastroenterologists. His academic involvement extends to national and international conferences, where he is frequently invited as a speaker in Lebanon, Abu Dhabi, Turkey, Rome, and the United Kingdom.

Profile: Orcid

Featured Publications

Boutari, R., Zayour, N., Hmedeh, A. N., Bashashi, D. K., Assaf, F., Al Tahan, J., Zrara, N., Al-Mokdad, N., Al Khatib, O., Zreik, A., et al. (2025). Prevalence, risk factors, and endoscopic findings of Helicobacter pylori infection among Lebanese patients undergoing gastroscopy: A retrospective study from a single tertiary center.

lingcong KONG | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

lingcong KONG | Drug Discovery and Development | Best Researcher Award

Prof. lingcong KONG at Jilin Agriculture University, China.

Prof. Lingcong Kong is a dedicated veterinary scientist with a Ph.D. in Preventive Veterinary Medicine from Jilin Agricultural University 🎓. He teaches courses like Veterinary Pharmacology and Animal Toxicology 🐄 and actively mentors students in national competitions 🏆. His research focuses on antimicrobial resistance, drug resistance mechanisms, and the development of resistance inhibitors in animal pathogens 🧫🦠. He has led numerous national and provincial projects, holds multiple patents for veterinary vaccines 💉, and has published extensively in high-impact journals 📚. His work significantly enhances diagnostic tools and contributes to sustainable animal healthcare.

Publication Profile 

Scopus

Education

Prof. Lingcong Kong began his academic journey at the Inner Mongolia University for Nationalities, where he earned his Bachelor of Veterinary Medicine from September 2006 to July 2010 🐾. He then pursued advanced studies at Jilin Agricultural University, completing a Master’s degree in Basic Veterinary Medicine between 2010 and 2013 🧪. Driven by a deep passion for animal health, he continued at the same institution to earn his Ph.D. in Preventive Veterinary Medicine from September 2013 to July 2016 🔬. His education laid a strong foundation for his impactful contributions to veterinary science and research.

Experience

Prof. Lingcong Kong is a dedicated educator who teaches undergraduate courses such as “Veterinary Pharmacology”, “Veterinary Pharmacology Experiment”, and “Animal Toxicology” 🐾. At the graduate level, he lectures on “Veterinary Drug Research and Creation”, “Advanced Pharmacology”, and “Veterinary Pharmacology and Toxicology” 💊. He actively mentors students in scientific competitions, leading them to prestigious honors like the 2022 Internet+ National Award (2nd Prize) 🏅, Provincial Award (1st Prize) 🥇, and innovation contests. His guidance also earned him the Outstanding Paper Award 📝 and the Dazenong Innovation Guidance Award in 2018 🎖️, highlighting his commitment to academic excellence and innovation.

Awards

Prof. Lingcong Kong has pioneered breakthroughs in detecting and combating drug-resistant animal pathogens 🐄🧫. His innovations include PCR-ELISA rapid detection, immunomagnetic bead enrichment, and high-throughput methods for resistance gene testing 🧪. He established a pathogenic bacteria resource library 📚 and developed functional probiotics to prevent animal diarrhea 💊. By identifying 8 key resistance inhibitor targets and 6 promising lead compounds, his work has revolutionized lab diagnostics, minimized economic losses in livestock, and enhanced ecological health 🌱💼. His efforts significantly advance animal healthcare and veterinary pharmacology across Jilin Province and beyond.

Research Focus 

Prof. Lingcong Kong focuses on veterinary pharmacology, particularly targeting antimicrobial resistance and infectious diseases in animals 🐄🦠. His cutting-edge research includes discovering novel natural inhibitors like coniferaldehyde and protocatechuic aldehyde to combat Staphylococcus aureus 🧪🔬. He also explores gene transfer mechanisms, antibiotic degradation pathways, and repurposing small molecules to inhibit bacterial enzymes like KPC-2 💊. By studying agents such as C15-bacillomycin D and antibacterial proteins from Bacillus velezensis, he contributes significantly to combatting multidrug-resistant pathogens in animal and environmental health.

Publication Top Notes

  • Discovery of coniferaldehyde as an inhibitor of caseinolytic protease to combat Staphylococcus aureus infections
  • Anti-infective therapy of inhibiting Staphylococcus aureus ClpP by protocatechuic aldehyde
  • Acidifiers promoted antibiotic resistance gene transfer via plasmid conjugation
  • Efficient degradation of tylosin by Kurthia gibsonii TYL-A1: performance, pathway, and genomics study
  • Repurposing tavaborole to combat resistant bacterial infections through competitive inhibition of KPC-2 and metabolic disruption
  • A Novel Protein Demonstrating Antibacterial Activity Against Multidrug-Resistant Escherichia coli Purified from Bacillus velezensis CB6
  • C15-bacillomycin D produced by Bacillus amyloliquefaciens 4-9-2 suppress Fusarium graminearum infection and mycotoxin biosynthesis

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Published on by Top Pharmaceutical

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Prof Serefnur Ozturk, Selcuk University Faculty of Medicine, Turkey

Prof. Şerefnur Öztürk is a leading expert in Neurology and Neurointensive Care, currently serving as the Head of the Neurology Department at Selcuk University, Turkey. She has held prominent roles including Vice Dean of the Faculty of Medicine (1996-2020) and President of the Turkish Neurological Society (2014-2021). With significant international influence, she contributes to the European Academy of Neurology and World Stroke Organization. She has led pivotal projects and trials in stroke and COVID-19-related neurological care. Prof. Öztürk is an acclaimed researcher with numerous influential publications in neurology.

Publication Profile

scopus

Education

Prof. Serefnur Ozturk has an impressive educational background. She began her medical studies at Ankara University Medical Faculty, where she earned her degree between 1980 and 1987. Her academic journey continued with a prestigious NATO Fellowship at Arizona University’s Stroke Center in 1993, further enhancing her expertise. In 1998, she advanced her knowledge in neurology and intensive care at Pittsburgh University, where she studied in their renowned Neurology and Intensive Care Department. These experiences have shaped Prof. Ozturk into a leading figure in her field. 🏥🎓🧠

Internship and Residencies

Prof. Serefnur Ozturk completed her internship at Ankara University Medical Faculty, where she gained valuable hands-on experience. Following this, she pursued her residency at Ankara Numune Research and Education Hospital, further honing her medical skills. Prof. Ozturk’s dedication to her field is reflected in her board certification, earning the Turkish Neurological Board Council Certificate. This certification recognizes her extensive expertise in neurology, solidifying her status as a trusted professional in her area of specialization. Her journey through internships, residencies, and board certification showcases her commitment to excellence. 🏥💉🧑‍⚕️🧠

Experiences

Prof. Serefnur Ozturk holds numerous prestigious leadership roles in neurology. She served as the President of the Turkish Neurological Society from 2014 to 2021 and is currently a member of various important committees, including the European Academy of Neurology (EAN) COVID-19 Task Force and the World Stroke Organization Global Policy Committee. Additionally, she is the Vice President of the European Environmental Neurology Society and has held positions within the World Federation of Neurology (WFN), including President of the Migrant Neurology Specialty Group. Prof. Ozturk is dedicated to advancing stroke care, cerebrovascular diseases prevention, and diversity in neurology. 🧠🌍👩‍⚕️🏥

Projects

Prof. Serefnur Ozturk has played a pivotal role in several major clinical trials and registries. She is the Principal Investigator of the EAN ENERGY COVID-19 Registry and the ENSEMBLE study, showcasing her leadership in critical research. Additionally, Prof. Ozturk serves as the National Coordinator for the Turkish COVID-19 Registry, the ENOS Trial, and TICH-2. Her expertise extends to key studies like the PERFORM Study (Phase III), FACT (Phase IV), and NAVIGATE-ESUS, where she also holds significant leadership positions. Her contributions to clinical research have greatly impacted neurology and stroke care. 🔬🧠🌍💉

Research Focus

Prof. Şerefnur Öztürk’s research focus lies predominantly in neurology, with a special emphasis on the neurological impacts of COVID-19, ischemic stroke, and innovative prognostic tools like the Selcuk Score. Her work is pivotal in advancing the understanding of how pandemics influence neurological care and the management of post-pandemic risks. Additionally, Prof. Öztürk contributes to cutting-edge stroke prevention and rehabilitation technologies, including web-based solutions. Her contributions drive progress in neuro-COVID research, stroke management, and global neurological health policies, showcasing her commitment to improving outcomes for patients worldwide. 🌍🧠💻

Publication Top Notes

The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future

Muscle mass as a modifier of stress response in acute ischemic stroke patients

Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers — An updated European Academy of Neurology consensus statement

The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data from 121 Surgically Treated Participants from the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial

General neurology: Current challenges and future implications

Climate Change and Stroke: A Topical Narrative Review

Dvora Joseph Davey | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Dvora Joseph Davey | Clinical Trials | Best Researcher Award 

Dr Dvora Joseph Davey, University of California, Los Angeles, UCLA, South Africa

Dr. Dvora Joseph Davey is a distinguished epidemiologist with a focus on infectious diseases, particularly HIV and STIs. Holding a Ph.D. in Epidemiology from UCLA, her research, mainly in sub-Saharan Africa, aims to reduce the burden of HIV through innovative interventions. As a Principal Investigator in clinical trials, Dr. Davey has contributed significantly to global HIV prevention efforts, especially for pregnant women. She is actively involved in policy-making with groups like the WHO and NIH, shaping global health initiatives. Her leadership, extensive research, and mentorship in global health make her an exemplary figure in public health. 🌍🔬💉

Publication Profile

google scholar

scopus

orcid

Education

Dr. Dvora Joseph Davey has an impressive academic background, beginning with a B.A. in International Affairs and French from the University of Colorado, Boulder, in 1998. She went on to earn a Master of Public Health (M.P.H.) in Population and Reproductive Health Sciences from Columbia University in 2003. Dr. Davey completed her Ph.D. in Epidemiology at the University of California, Los Angeles, in 2016, followed by a fellowship in Epidemiology of HIV at the University of North Carolina in 2017. She furthered her expertise with a postdoctoral fellowship in Global HIV Prevention at UCLA in 2018. 🌍📚

Scientific Appointments

Dr. Dvora Joseph Davey has held several prestigious positions throughout her career. Currently, she serves as an Associate Professor in Infectious Diseases and Epidemiology at UCLA’s School of Medicine and School of Public Health, respectively. She also holds honorary roles at the University of Cape Town and Desmond Tutu Health Foundation. Dr. Davey’s research includes being the Principal Investigator on a study about sexual behavior and PrEP acceptability. Her past positions include HIV Director at Population Services International in Mozambique and Director at the Rwanda-Emory HIV Research Group. With her diverse roles, Dr. Davey has had a significant global impact. 🌍🩺📊

Professional Memberships

Dr. Dvora Joseph Davey has made significant contributions to the field of HIV and reproductive health, serving as an Assistant Editor for renowned journals such as AIDS, JIAS, and PloS Global Health. She is also an active member of the South African Clinical Research Association and the American Public Health Association. Her honors include invitations to present at major conferences like HIVR4P 2024 in Peru and WHO Working Group meetings. Dr. Davey has co-chaired several influential research working groups, including on PrEP in pregnancy, and received multiple awards, including UCLA’s Epidemiology Department Summer Fellowship. 🌍📚🎤

Awards

Dr. Dvora Joseph Davey is a renowned researcher whose work focuses on HIV prevention and treatment, particularly in pregnant and breastfeeding women. Her studies address key challenges in high HIV incidence communities, especially in Sub-Saharan Africa. Dr. Davey investigates Pre-exposure Prophylaxis (PrEP) access, adherence, and effectiveness among pregnant women, emphasizing the need for female-controlled HIV prevention methods during vulnerable periods. Additionally, she explores the integration of STI testing, alcohol use, and the impact of intimate partner violence on HIV risk. Her contributions significantly influence HIV-related healthcare policies, aiming to reduce transmission and improve outcomes in these populations. 👩‍🔬🌍💉

Policy Involvement

Dr. Dvora Joseph Davey has made significant contributions to national and international HIV and STI policy-making. Her leadership in key working groups, including the National PrEP and Prevention of Vertical Transmission of HIV Working Groups, as well as the World Health Organization’s Working Group on Long-Acting PrEP in pregnancy, highlights her expertise and influence. These positions enable Dr. Davey to play a pivotal role in translating scientific research into actionable policies, ensuring her work impacts not only the scientific community but also global health policies. Her efforts amplify the reach of her research, making a lasting impact on public health worldwide. 🌍🩺💉

Leadership

Dr. Dvora Joseph Davey’s leadership in managing large-scale clinical trials and mentoring emerging public health and epidemiology professionals showcases her dedication to education and capacity-building in global public health. As a recipient of the prestigious NIH/Fogarty International Research Scientist Development Award (IRSDA) and the follow-on R01 award, Dr. Davey has solidified her position as a thought leader in the field. Her commitment to fostering continuous learning and improvement within the global health community reflects her deep influence and dedication to advancing public health practices worldwide. 🎓🌍💉👩‍🔬

Ongoing Projects

Dr. Dvora Joseph Davey’s ongoing research, supported by NIH and Gilead Corporation, plays a crucial role in addressing HIV within vulnerable populations. Her work on projects like PrEP-PP and SCOPE-PP, alongside innovative initiatives such as a community-based peer-led intervention to tackle alcohol use and HIV risk in pregnant women, highlights her proactive approach to solving complex public health challenges. Dr. Davey’s research aims to create effective, targeted solutions that address the unique needs of at-risk communities, contributing significantly to advancing HIV prevention and care efforts. 💡🧑‍🔬🩺🌍

Research Focus

Dr. Dvora Joseph Davey is a prominent researcher specializing in HIV prevention, sexually transmitted infections (STIs), and maternal health. Her work focuses on pre-exposure prophylaxis (PrEP) for HIV, examining its safety and efficacy among pregnant and postpartum women. She also explores STI diagnostics, point-of-care testing, and the prevalence of curable STIs in low- and middle-income countries. Her research seeks to improve access to health interventions, particularly for vulnerable populations like men who have sex with men and transgender women. Dr. Davey’s contributions help shape public health strategies for HIV prevention and sexual health. 🦠💉

Publication Top Notes

 

Assist Prof Dr. AYŞEGÜL KILIÇLI|Clinical Trials| Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr. AYŞEGÜL KILIÇLI|Clinical Trials |Best Researcher Award|

Assist Prof Dr. AYŞEGÜL KILIÇLI at mus alparslan university, Turkeys

PROFILE  

scopus

Orcid

 

Early Academic Pursuits 🎓

Assist. Prof. Dr. Ayşegül KILIÇLI embarked on her academic journey with a profound dedication to the field of nursing, focusing specifically on obstetrics and gynecology. She earned her Bachelor’s degree in Nursing from a reputable institution, where her commitment to the healthcare field began to shine. Driven by a desire to enhance her expertise and contribute significantly to her field, she pursued a Master’s degree in Obstetric and Gynecology Nursing. This was followed by rigorous research and a doctoral degree (Ph.D.) in the same domain, equipping her with advanced knowledge and research skills essential for a successful academic and professional career.

Professional Endeavors 👩‍⚕️

Dr. KILIÇLI is currently serving as an Assistant Professor in the Obstetric and Gynecology Nursing Department at Muş Alparslan University Health Sciences Faculty. Her role involves teaching, mentoring, and guiding students through their academic and clinical experiences. Her professional journey reflects a commitment to advancing nursing education and practice. She is actively involved in several research projects and has published extensively in high-impact journals. Her work focuses on improving healthcare practices and patient outcomes, particularly in the field of obstetrics and gynecology.

Contributions and Research Focus 🔬

Dr. KILIÇLI’s research is primarily concentrated on obstetric and gynecology nursing. One of her notable completed research projects is a randomized controlled trial examining the effect of neurolinguistic programming and progressive muscle relaxation exercises on breastfeeding success and self-efficacy. This innovative study has been instrumental in advancing knowledge about non-pharmacological interventions in maternal care. Her research contributions are reflected in her publications in SCI-E journals, where her work is highly regarded by the scientific community.

Accolades and Recognition 🏆

Dr. KILIÇLI’s research excellence and contributions to the field have earned her recognition in various forums. Her work has been cited in prestigious databases, including Science Citation Index-Expanded (SCI-E), Scopus, and Web of Science (ESCI). She is celebrated for her significant contributions to advancing obstetric and gynecology nursing practices. Her role as a corresponding researcher further highlights her leadership and expertise in the field, establishing her as a respected figure in the global research community.

Impact and Influence 🌍

Dr. KILIÇLI’s impact extends beyond her research and academic contributions. Her work has positively influenced clinical practices, particularly in improving breastfeeding outcomes and maternal self-efficacy. By integrating innovative approaches into her research, she has contributed to the development of more effective strategies in nursing care. Her influence is also evident in the academic and professional growth of her students, who benefit from her extensive knowledge and mentorship.

Legacy and Future Contributions 🔮

As a pioneering researcher in obstetric and gynecology nursing, Dr. KILIÇLI is poised to leave a lasting legacy in her field. Her dedication to advancing maternal and child health through research and education is commendable. Looking ahead, Dr. KILIÇLI plans to continue her research with a focus on exploring new interventions and improving existing practices. Her future contributions are expected to further enhance nursing care practices and patient outcomes, reinforcing her position as a leading expert in her field.

🎓Publication 

The effect of neurolinguistic programming and progressive muscle relaxation exercises on breastfeeding success and breastfeeding self-efficacy: A randomized controlled trial

  • Authors   :Kiliçli, A., Gül, S.
  • Journal    :Explore
  • Year         :2024

Effect of Reflexology on Pain, Fatigue, Sleep Quality, and Lactation in Postpartum Primiparous Women After Cesarean Delivery: A Randomized Controlled Trial

Stress, Anxiety, and Postpartum Depression in Parents with Premature Infants in Neonatal Intensive Care Unit

Stigmatizing attitudes, beliefs, and actions of women towards abortion in rural regions with high fertility

Women’s reproductive behaviour and perspectives on fertility, and their modifying factors, in a Turkish province with a high fertility rate

Dr. Jinat Alam| Clinical Trials|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Jinat Alam, Clinical Trials,Best Researcher Award

Dr. Jinat Alam, at icddr,b,Bangladesh

PROFILE

scopus

Orcid

Google Scholar 

🎓Early Academic Pursuits :

Dr. Jinat Alam embarked on her academic journey with a Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Dhaka, Bangladesh. She completed her MBBS from Ibn Sina Medical College and Hospital in June 2014 with an overall GPA of 3.00 (WES Evaluation). Her passion for public health led her to pursue a Master’s in Public Health (MPH) from North South University, Bangladesh, where she excelled with an impressive GPA of 3.83 out of 4.00, completing the program in March 2024. Her major courses included Epidemiology, Biostatistics, Research Methodology, and Health System and Management, which laid a strong foundation for her future endeavors in the field of public health.

🏥Professional Endeavors :

Dr. Alam’s professional journey is marked by significant roles and contributions in various capacities at icddr,b, an international health research institution based in Bangladesh. She began her career as a Clinical Fellow at icddr,b, from March 2017 to August 2019, where she maintained regular hospital patient care and participated in clinical duties in Pediatrics and Internal Medicine under the Nutrition and Clinical Services Division. Her responsibilities included addressing Gastrointestinal Diseases, Tuberculosis and Lung Diseases, Maternal and Child Nutrition, and Critical Care.

From September 2019 to November 2023, she served as a Project Research Physician, leading randomized controlled clinical trials and presenting her findings at various scientific forums. Currently, she holds the position of Study Physician at icddr,b, where she continues to contribute to research protocol writing, protocol development, and community trials.

📚Contributions and Research Focus :

Dr. Alam’s research focus spans a wide range of public health issues, particularly in the areas of malnutrition, environmental enteric dysfunction, and complementary food development. She has been involved in several pivotal research projects, including:

  • Efficacy Trial of Microbiota Directed Food on Children with Moderate Acute Malnutrition (Co-Investigator, PR-24031, NCT06305442)
  • Assessment of Body Composition in Bangladeshi Children and Validation of Skinfold Thickness-Based Body Composition Prediction Equations (Principal Investigator, PR-24007)
  • Role of L-Carnitine Supplementation on Rate of Weight Gain and Biomarkers of Environmental Enteric Dysfunction in Children with Severe Acute Malnutrition (Principal Investigator, PR-21046, NCT05083637)
  • Development of Shelf-Stable, Locally-Sourced, Microbiota-Directed Complementary Foods for Children with Undernutrition (Study Physician, PR-21019)
  • A Bayesian approach to predict the role of dietary diversity, water, sanitation and hygiene practice, enteric infections and impaired gut health on multiple micronutrient deficiencies in children at 24 months of age (Project Research Physician, PR-20051)
  • Zinc sulfate acceptability study in children with acute diarrhea (Project Research Physician, PR-19033, NCT04039828)

🏆Accolades and Recognition :

Dr. Alam’s dedication and excellence in research have been recognized through various awards. She received the ‘Young Scientist Award’ under the ‘Rainy Day grant fund’ of icddr,b, a competitive research grant of $25,000 for a duration of one year. Additionally, her outstanding performance in oral presentations earned her the ‘Best Presenter Award’ at the Executive Director’s Scientific Seminar in 2023.

🌍Impact and Influence :

Dr. Alam’s work has had a profound impact on the field of public health in Bangladesh and beyond. Her research on malnutrition and environmental enteric dysfunction has contributed to a better understanding of these critical issues and has paved the way for developing effective interventions. Her involvement in clinical trials and research projects has influenced public health policies and practices, benefiting countless children and communities.

🌟Legacy and Future Contributions :

Dr. Alam’s legacy is defined by her relentless pursuit of excellence in public health research and her commitment to improving the lives of vulnerable populations. Her work at icddr,b and her contributions to various research projects have set a high standard for future public health professionals. As she continues her journey, Dr. Alam aims to further her research on malnutrition, develop innovative solutions for public health challenges, and mentor the next generation of public health researchers.

📝Conclusion :

Dr. Jinat Alam’s journey is a testament to her dedication, expertise, and impact in the field of public health and medicine. Her early academic pursuits, professional endeavors, research contributions, accolades, and future aspirations highlight her as a distinguished figure in her field. Her legacy will continue to inspire and influence public health initiatives, making a lasting difference in the lives of many.

🎓Publication 

Inadequate vitamin C intake and intestinal inflammation are associated with multiple micronutrient deficiency in young children: results from a multi-country birth cohort study

  • Authors   :Shah Mohammad Fahim, Md Ashraful Alam, Jinat Alam, Md Amran Gazi, Mustafa Mahfuz, Tahmeed Ahmed.
  • Journal    :Nutrients
  • Year         :2022

Role of L-Carnitine supplementation on rate of weight gain and biomarkers of Environmental Enteric Dysfunction in children with severe acute malnutrition: A protocol for a …

    • Authors :Jinat Alam, Md Ridwan Islam, Shah Mohammad Fahim, Md Amran Gazi, Tahmeed Ahmed
    • Journal   :Plos one
    • Year       : 2022

Effects of L-Carnitine Supplementation on the Rate of Weight Gain and Biomarkers of Environmental Enteric Dysfunction in Children with Severe Acute Malnutrition: A Double-Blind …

  • Authors  :Jinat Alam, Shah Mohammad Fahim, Md Ridwan Islam, Md Ashraful Alam, Md Amran Gazi, Tahmeed Ahmed
  • Journal    :The Journal of Nutrition
  • Year         :  2024

Nutritional profiles and zinc supplementation among children with diarrhea in Bangladesh

  • Authors  :Jinat Alam, Sharika Nuzhat, Shebab Md Billal, Tahmeed Ahmed, Azharul Islam Khan, Md Iqbal Hossain
  • Journal   :The American Journal of Tropical Medicine and Hygiene
  • Year        :   2023

New formulation zinc sulphate acceptability and adherence in children with acute diarrhoea: a prospective, open‐label, interventional study in Bangladesh

  • Authors  :Sharika Nuzhat, Tahmeed Ahmed, Jinat Alam, Shebab Md Billal, Azharul Islam Khan, Md Iqbal Hossain
  • Journal   :Journal of Paediatrics and Child Health
  • Year        :  2022